A Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies

Weill Cornell Medical College, New York

Local Institution - 0007, Baltimore

Barbara Ann Karmanos Cancer Institute, Detroit

Local Institution - 0010, St Louis

Local Institution - 0006, Houston

Local Institution - 0002, Portland

Local Institution - 0001, Seattle

Local Institution - 0004, Boston

Local Institution - 0011, Vancouver

Local Institution - 0012, Toronto